Skip to main content

Table 1 Demographic and clinical characteristics of 20 subjects diagnosed with BPD completing a 12-week trial with YGS

From: Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study

Sociodemographic and clinical variables

Value

Sex, N (male/female)

22/18

Age, mean±SD, years

22.7 ± 7.3

IQ

88.9 ± 7.3